PD-RX Pharmaceuticals News

News

Ticker

PDRX

ISIN

US6932981011

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

PD-RX Pharmaceuticals Eulerpool News

PD-RX Pharmaceuticals Stock News

PD-RX Pharmaceuticals is being monitored by journalists and investors worldwide. We gather the latest PD-RX Pharmaceuticals news here.

January 21·
SeekingAlpha
Cedar Creek Partners Q4 2025 Expert Market Exposure
July 24·
SeekingAlpha
Cedar Creek Partners Q2 2025 Results
April 16·
SeekingAlpha
Cedar Creek Partners Q1 2025 Results
February 11·
SeekingAlpha
Cedar Creek Partners 2024 Results
October 24·
SeekingAlpha
Cedar Creek Partners Q3 2024 Results
July 31·
SeekingAlpha
Cedar Creek Partners Q2 2024 Results

PD-RX Pharmaceuticals Stock Press Releases

PD-RX Pharmaceuticals regularly publishes news on the company's website that are relevant for investors.

PD-RX Pharmaceuticals News 2026

This page contains all current news, analysis and press releases for PD-RX Pharmaceuticals stock (PDRX, ISIN: US6932981011). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at PD-RX Pharmaceuticals.

PD-RX Pharmaceuticals Stock

PD-RX Pharmaceuticals PD-RX Pharmaceuticals Inc, headquartered in Oklahoma City, US, operates in the Health Care sector. The company provides pharmaceutical services and was founded in 1995. It went public on 17 December 2001, listing on the stock market. PD-RX focuses on delivering pharmaceutical solutions within the health care industry.